Search Results - "Latino, N"

ESMO-Magnitude of Clinical Benefit Scale version 1.1 by Cherny, N.I., Dafni, U., Bogaerts, J., Latino, N.J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M.J., de Vries, E.G.E.

“…The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.0 (v1.0) was published in May 2015 and was the first version of a validated and reproducible…”
Get full text

ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe by Bayle, A., Bonastre, J., Chaltiel, D., Latino, N., Rouleau, E., Peters, S., Galotti, M., Bricalli, G., Besse, B., Giuliani, R.

“…Access to biomolecular technologies has become an essential requirement to ensure optimal and timely treatment of patients with cancer. This study sought to…”
Get full text

The ‘critical mass’ survey of palliative care programme at ESMO designated centres of integrated oncology and palliative care by Hui, D., Cherny, N., Latino, N., Strasser, F.

“…The ESMO Designated Centres (ESMO-DCs) of Integrated Oncology and Palliative Care (PC) Incentive Programme has grown steadily. We aimed to characterise the…”
Get full text

Reply to the Letter to the Editor regarding 'Overcoming Barriers in Biomarker Testing' J. García-Foncillas et al by Bayle, A, Chaltiel, D, Latino, N, Rouleau, E, Peters, S, Galotti, M, Bricalli, G, Besse, B, Giuliani, R, Bonastre, J

Get more information

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit by Oosting, S.F., Barriuso, J., Bottomley, A., Galotti, M., Gyawali, B., Kiesewetter, B., Latino, N.J., Martinelli, F., Pe, M., Pentheroudakis, G., Roitberg, F., Vachon, H., de Vries, E.G.E., Piccart, M., Cherny, N.I.

“…The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) has been developed to grade clinical benefit of cancer therapies…”
Get full text

Access to essential anticancer medicines for children and adolescents in Europe by Vassal, G., Kozhaeva, O., Griskjane, S., Arnold, F., Nysom, K., Basset, L., Kameric, L., Kienesberger, A., Kamal, S., Cherny, N., Bricalli, G., Latino, N., Kearns, P.

“…Essential anticancer medicines are an indispensable component of multidisciplinary treatment of paediatric malignancies. A European Society for Medical…”
Get full text

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0 by Kiesewetter, B., Dafni, U., de Vries, E.G.E., Barriuso, J., Curigliano, G., González-Calle, V., Galotti, M., Gyawali, B., Huntly, B.J.P., Jäger, U., Latino, N.J., Malcovati, L., Oosting, S.F., Ossenkoppele, G., Piccart, M., Raderer, M., Scarfò, L., Trapani, D., Zielinski, C.C., Wester, R., Zygoura, P., Macintyre, E., Cherny, N.I.

“…The European Society for Medical Oncology (ESMO)-Magnitude of Clinical Benefit Scale (MCBS) has been accepted as a robust tool to evaluate the magnitude of…”
Get full text

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey by Kreye, G., Lundeby, T., Latino, N., Galotti, M., Kaasa, S.

“…The European Society for Medical Oncology (ESMO) Designated Centres (DCs) of Integrated Oncology and Palliative Care is an incentive programme established in…”
Get full text

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain by Roitberg, F., Amaral, T., Cherny, N.I., Giuliani, R., Latino, N.J., Galotti, M., Bricalli, G., Curigliano, G., Pentheroudakis, G., Trapani, D.

“…Cancer is a global public health problem, requiring efficient health system investments to deliver sustainable impact on population health. Access to medicines…”
Get full text

Reply to the letter to the editor ‘Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies’ by Cherny, N.I., Dafni, U., Bogaerts, J., Latino, N.J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M.J., de Vries, E.G.E.

Get full text

Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience by Latino, N.J., Galotti, M., Cherny, N.I., de Vries, E.G.E., Douillard, J.-Y., Kaidarova, D., Ilbawi, A.

“…In Kazakhstan, cancer is the second leading cause of death with a major public health and economic burden. In the last decade, cancer care and cancer medicine…”
Get full text

Reply to the letter to the editor ‘ESMO-MCBS v1.1: statistical and patient relevant shortcomings’ by Emprechtinger et al by Cherny, N.I., Dafni, U., Piccart, M., Latino, N.J., Douillard, J.-Y., Bogaerts, J., Karlis, D., Zygoura, P., Pentheroudakis, G., Tabernero, J., Zielinski, C., de Vries, E.G.E.

Get full text

Reply to the letter to the editor ‘Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?’ by Del Paggio by Cherny, N.I., Dafni, U., Bogaerts, J., Latino, N.J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M.J., de Vries, E.G.E.

Get full text

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines by Zarkavelis, G., Amylidi, A.L., Verbaanderd, C., Cherny, N.I., Metaxas, Y., de Vries, E.G.E., Zygoura, P., Amaral, T., Jordan, K., Strijbos, M., Dafni, U., Latino, N., Galotti, M., Lordick, F., Giuliani, R., Pignatti, F., Pentheroudakis, G.

“…Off-label use of medicines is generally discouraged. However, several off-patent, low-cost cancer medicines remain off-label for indications in which they are…”
Get full text

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers by Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, Piccart, M J, Bogaerts, J, Tabernero, J, Latino, N J, de Vries, E G E

“…The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a standardised, generic, validated tool to stratify the magnitude of clinical benefit that can be…”
Get full text

Characteristics and level of integration of ESMO Designated Centres of integrated oncology and palliative care by Hui, D., Cherny, N., Latino, N., Strasser, F.

Get full text